The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Open accessAbstract
Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi's sarcoma (KS), intravenously (i.v.) injected human mesenchymal stem cells (MSCs) home to sites of tumorigenesis and potently inhibit tumor growth. We further show that human MSCs can inhibit the in vitro activation of the Akt protein kinase within some but not all tumor and primary cell lines. The inhibition of Akt activity requires the MSCs to make direct cell–cell contact and can be inhibited by a neutralizing antibody against E-cadherin. We further demonstrate that in vivo, Akt activation within KS cells is potently down-regulated in areas adjacent to MSC infiltration. Finally, the in vivo tumor-suppressive effects of MSCs correlates with their ability to inhibit target cell Akt activity, and KS tumors engineered to express a constitutively activated Akt construct are no longer sensitive to i.v. MSC administration. These results suggest that in contrast to other stem cells or normal stromal cells, MSCs possess intrinsic antineoplastic properties and that this stem cell population might be of particular utility for treating those human malignancies characterized by dysregulated Akt.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“There they can potentiate further tumorigenesis via differentiation into tumor-nurturing stroma (TAF, myofibroblasts) [82, 104], direct cell contact interaction with cancer cells [105, 106] or release of paracrine factors (Table 2).”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [106]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The anti-tumorigenic and pro-apoptotic effect of MSCs results from the suppression of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) signaling pathway in some cancer types [59].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Existing data from pre-clinical studies regarding the pro-apoptotic effect of MSCs on cancer cells through the downregulation of PI3K/Akt pathway support this antitumor potential in hepatocellular carcinoma, glioma cells, Kaposi's sarcoma, and prostate and breast cancer [61], [62], [63], [64], [65].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [61]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,654
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., & Chopp, M. (2001) · Stroke · doi:10.1161/01.str.32.4.1005 · Cited by 1,764
Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., & Ringdén, O. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00110-3 · Cited by 1,623
Research works printed but not linked: 8
- 2004, Panminerva Med., 46, 61
- 2000, Cancer Res., 60, 1254
- 1999, Cancer Res., 59, 5002
- 2004, Blood., 105, 1815
- 2004, Blood., 104, 1217
- 1993, Cancer Biol., 4, 231
- 2003, Cancer Cell Int., 3, 17
- 2003, Cancer Res., 63, 5821
Cited by
Items 401–500 of 747
Bidirectional and Opposite Effects of Naïve Mesenchymal Stem Cells Ontumor Growth and Progression
Rahmatizadeh, F., Aziz, S. G., Khodadadi, K., Ataei, M. L., Ebrahimie, E., Rad, J. S., & Pashaiasl, M. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.063 · Cited by 25
Yang, X., Zhu, L., Ma, Y., Gao, J., Liu, S., Gao, Y., & Wang, G. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0093-9 · Cited by 25
Adipose Tissue-Derived Mesenchymal Stem Cells for Breast Tisssue Regeneration
Banani, M. A., Rahmatullah, M., Farhan, N., Hancox, Z., Yousaf, S., Arabpour, Z., Moghaddam, Z. S., Mozafari, M., & Sefat, F. (2021) · Regenerative Medicine · doi:10.2217/rme-2020-0045 · Cited by 25
Picinich, S. C., Glod, J. W., & Banerjee, D. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.11.011 · Cited by 26
Widder, M., Lützkendorf, J., Caysa, H., Unverzagt, S., Wickenhauser, C., Benndorf, R. A., Schmoll, H., Müller‐Tidow, C., Müller, T., & Müller, L. P. (2015) · International Journal of Cancer · doi:10.1002/ijc.29844 · Cited by 26
Multiple myeloma and bone marrow mesenchymal stem cells’ crosstalk: Effect on translation initiation
Attar‐Schneider, O., Zismanov, V., Dabbah, M., Tartakover‐Matalon, S., Drucker, L., & Lishner, M. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22378 · Cited by 24
A20 plays a critical role in the immunoregulatory function of mesenchymal stem cells
Dang, R., Yang, Y., Zhang, L., Cui, D., Hong, B., Li, P., Lin, Q., Wang, Y., Wang, Q., Xiao, F., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12849 · Cited by 25
Li, T., Zhang, J., Zhang, N., Zhang, N., Zeng, Y., Tang, S., Tao, Z., Qu, X., Jia, J., Zhu, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22712 · Cited by 24
Self-citationByun, C. S., Hwang, S., Woo, S.-H., Kim, M. Y., Lee, J. S., Lee, J. I., Kong, J. H., Bae, K. S., Park, I. H., Kim, S. H., et al. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.41354 · Cited by 27
Razmkhah, M., Mansourabadi, Z., Mohtasebi, M. S., Talei, A., & Ghaderi, A. A. (2017) · Cell Biology International · doi:10.1002/cbin.10905 · Cited by 23
Lim, Y., Lee, J., Lee, Y. S., Lee, B., & Wang, S.-G. (2012) · Clinical and Experimental Otorhinolaryngology · doi:10.3342/ceo.2012.5.2.86 · Cited by 22
Identification of Predictive Gene Markers for Multipotent Stromal Cell Proliferation
Bellayr, I. H., Marklein, R. A., Surdo, J. L., Bauer, S. R., & Puri, R. K. (2016) · Stem Cells and Development · doi:10.1089/scd.2015.0374 · Cited by 22
Merino, J. J., & Cabaña-Muñoz, M. E. (2023) · Micromachines · doi:10.3390/mi14112068 · Cited by 25
Taheri, M., Tehrani, H. A., Dehghani, S., Alibolandi, M., Arefian, E., & Ramezani, M. (2024) · Medicinal Research Reviews · doi:10.1002/med.22023 · Cited by 21
Ultrasound-Mediated Mesenchymal Stem Cells Transfection as a Targeted Cancer Therapy Platform
Haber, T., Baruch, L., & Machluf, M. (2017) · Scientific Reports · doi:10.1038/srep42046 · Cited by 23
Zhou, Y. L., Dong, Y., Zhang, A., Wu, J., & Sun, Q. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1214190 · Cited by 22
Human Adipose Derived Stem Cells Induced Cell Apoptosis and S Phase Arrest in Bladder Tumor
Yu, X., Su, B., Ge, P., Wang, Z., Li, S., Huang, B., Gong, Y., & Lin, J. (2015) · Stem Cells International · doi:10.1155/2015/619290 · Cited by 21
Nieß, H., Thomas, M. N., Schiergens, T. S., Kleespies, A., Jauch, K., Bruns, C. J., Werner, J., Nelson, P. J., & Angele, M. K. (2016) · Innovative Surgical Sciences · doi:10.1515/iss-2016-0005 · Cited by 25
Allen, H., Shraga‐Heled, N., Blumenfeld, M., Dego-Ashto, T., Fuchs‐Telem, D., Gilert, A., Aberman, Z., & Ofir, R. (2018) · Scientific Reports · doi:10.1038/s41598-017-18428-1 · Cited by 21
Giorgi, U. D., Cohen, E. N., Gao, H., Mego, M., Lee, B.-N., Lodhi, A., Cristofanilli, M., Lucci, A., & Reuben, J. M. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.9.15178 · Cited by 21
The Dual Role of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Carcinogenesis
Gilazieva, Z., Ponomarev, A. S., Rizvanov, A. A., & Solovyeva, V. V. (2022) · Biology · doi:10.3390/biology11060813 · Cited by 21
The myofibroblast in connective tissue repair and regeneration
Hinz, B. (2010) · Elsevier eBooks · doi:10.1533/9781845697792.39 · Cited by 24
Ahn, J., Chae, J.-S., Coh, Y.-R., Jung, W., Lee, H. W., Shin, I.-S., Kang, S., & Youn, H. (2014) · PubMed · Cited by 20
Application of Stem Cells in Targeted Therapy of Breast Cancer: A Systematic Review
Madjd, Z., Gheytanchi, E., Erfani, E., & Asadi‐Lari, M. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.5.2789 · Cited by 21
Spath, C., Schlegel, F., Leontyev, S., Mohr, F., & Dhein, S. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00042 · Cited by 21
Sankaranarayanan, S., Manimaran, K., Sharma, R., & Perumal, S. (2016) · Annals of Maxillofacial Surgery · doi:10.4103/2231-0746.186128 · Cited by 20
Effects of mesenchymal stem cells harboring the Interferon-β gene on A549 lung cancer in nude mice
Chen, X. T., Wang, K., Chen, S., & Chen, Y. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.01.013 · Cited by 22
Wu, Z., Liu, W. Y., Wang, Z., Zeng, B., Peng, G., Niu, H., Chen, L., Liu, C., Hu, Q., Zhang, Y., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-1112-7 · Cited by 21
Dzobo, K. (2021) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0049 · Cited by 25
Ho, Y. K., Loke, K. M., Woo, J. Y., Lee, Y. L., & Too, H. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03198-z · Cited by 19
The Role of Mesenchymal Stem Cells in the Induction of Cancer-Stem Cell Phenotype
Jing, Y., Liang, W., Zhang, L., Tang, J., & Huang, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.817971 · Cited by 20
Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery
Ghaleh, H. E. G., Vakilzadeh, G., Zahiri, A., & Farzanehpour, M. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01232-y · Cited by 20
Human Mesenchymal Stem Cells Promote Cancer Motility and Cytokine Secretion in vitro
Scherzed, A., Hackenberg, S., Radeloff, A., Froelich, K., Rak, K., Hagen, R., & Kleinsasser, N. H. (2013) · Cells Tissues Organs · doi:10.1159/000356731 · Cited by 22
Chen, F., Zhou, K., Zhang, L., Ma, F., Chen, D., Cui, J., Feng, X., Yang, S., Chi, Y., Han, Z., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0621 · Cited by 19
Letourneau, P. A., Menge, T. D., Wataha, K. A., Wade, C. E., Cox, C. S., Holcomb, J. B., & Pati, S. (2011) · Journal of Tissue Science & Engineering · doi:10.4172/2157-7552.s3-001 · Cited by 22
Dabbah, M., Attar‐Schneider, O., Zismanov, V., Matalon, S. T., Lishner, M., & Drucker, L. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1115-510rr · Cited by 19
Amorim, S., da Costa, D. S., Pashkuleva, I., Reis, C. A., Reis, R. L., & Pires, R. A. (2020) · Biomaterials Science · doi:10.1039/d0bm00843e · Cited by 22
Engineering Cell‐Based Systems for Smart Cancer Therapy
Mirkhani, N., Gwisai, T., & Schuerle, S. (2021) · Advanced Intelligent Systems · doi:10.1002/aisy.202100134 · Cited by 18
The uncertain role of unmodified mesenchymal stem cells in tumor progression: what master switch?
Zhang, L., Xiang, J., & Li, G. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt170 · Cited by 20
Mirabdollahi, M., Sadeghi‐Aliabadi, H., & Javanmard, S. H. (2020) · PubMed Central · doi:10.22038/ijbms.2020.42477.10020 · Cited by 21
Jazedje, T., Ribeiro, A. L., Pelatti, M., Bueno, H. M. D. S., Nagata, G. Y., Trierveiler, M., Rodrigues, E. G., & Zatz, M. (2015) · Stem Cells International · doi:10.1155/2015/796215 · Cited by 19
Hu, W., Wang, W., Jiang, X., Wang, Z., & Lin, R. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04028-3 · Cited by 20
Jiang, J., Wei, D.-E., SUN, L., Wang, Y., Wu, X., Li, Y., Fang, Z., Shang, H. F., & Wei, Z. (2013) · Oncology Reports · doi:10.3892/or.2013.2898 · Cited by 18
Reduction of tumorigenicity by placental extracts.
Marleau, A. M., McDonald, G., Koropatnick, J. D., Chen, C.-S., & Koos, D. (2012) · PubMed · Cited by 18
Are Mesenchymal Stem Cells So Bloody Great After All?
Marfy-Smith, S., & Clarkin, C. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0026 · Cited by 19
Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers?
Ghaderi, A. A., & Abtahi, S. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9824-y · Cited by 18
Razmkhah, M., Abtahi, S., & Ghaderi, A. A. (2018) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x13666180816114809 · Cited by 21
Aziz, M. T. A., Khaled, H. M., Hindawi, A. E., Roshdy, N. K., Rashed, L. A., Sabry, D., Hassouna, A., Taha, F., & Ali, W. I. (2013) · BioMed Research International · doi:10.1155/2013/129629 · Cited by 18
Li, Y., Zhao, Y., Cheng, Z., Zhan, J., Sun, X., Qian, H., Zhu, W., & Xu, W. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.02.001 · Cited by 18
Zolochevska, O., Shearer, J. J., Ellis, J., Fokina, V. M., Shah, F. S., Gimble, J. M., & Figueiredo, M. L. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2013.11.012 · Cited by 19
The role of bone marrow-derived stem cells in lung regeneration and repair
Janes, S. M. (2008) · StemBook · doi:10.3824/stembook.1.20.1 · Cited by 20
Aalhate, M., Mahajan, S., Dhuri, A., & Singh, P. K. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103331 · Cited by 17
Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
Bank, J. R., Rabelink, T. J., de Fijter, J. W., & Reinders, M. E. J. (2015) · Journal of Immunology Research · doi:10.1155/2015/391797 · Cited by 18
Yu, J., Chan, S., Fung, M. K.-L., & Chan, G. (2021) · BMC Cancer · doi:10.1186/s12885-021-08090-2 · Cited by 19
Antoon, R., Wang, X., Saleh, A. H., Warrington, J., Hedley, D. W., & Keating, A. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2021.12.005 · Cited by 18
Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges
Ma, Z., Hua, J., Liu, J., Zhang, B., Wang, W., Yu, X., & Xu, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043559 · Cited by 20
Zhou, J., Liang, T., Wang, D., Li, L., Cheng, Y., Guo, Q., & Zhang, G. (2018) · Stem Cells International · doi:10.1155/2018/1241323 · Cited by 18
Letko-Khait, N., Dayan, N. M., Kaneti, G., Fried, L., Anavy, N. C., Bronshtein, T., & Machluf, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.005 · Cited by 17
Mezey, Mayer, B., & Németh, K. (2009) · Oral Diseases · doi:10.1111/j.1601-0825.2009.01605.x · Cited by 17
Mohammadpour, H., & Majidzadeh‐A, K. (2015) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2015.02.004 · Cited by 16
Zhang, Y., Liu, C., Wang, T., Kong, F., Zhang, H., Yi, J., Dong, X., Duan, H., Tao, N., Yang, Y., et al. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.01.007 · Cited by 16
Usha, L., Rao, G., Christopherson, K. W., & Xu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067895 · Cited by 18
Mesenchymal Stem Cells and Cancer — for Better or for Worse?
Yen, B. L., & Yen, M. (2008) · doi:10.29685/jcm.200804.0001 · Cited by 16
Seyhoun, I., Hajighasemlou, S., Ai, J., Hosseinzadeh, F., Mirmoghtadaei, M., Seyhoun, S. M., Parseh, B., Abdolahi, S., Ghazvinian, Z., Shadnoush, M., et al. (2019) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2019.20.1.263 · Cited by 16
Sun, Y., Zhang, B., Duan, J., Wu, H., Wang, B.-Q., Yu, Z., Yang, W., Shan, Y., Zhou, M., & Zhang, Q. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033729 · Cited by 16
Effect of Human Mesenchymal Stem Cells on the Growth of HepG2 and Hela Cells
Long, X., Matsumoto, R., Yang, P., & Uemura, T. (2013) · Cell Structure and Function · doi:10.1247/csf.12029 · Cited by 17
Carnet, O., Lecomte, J., Masset, A., Primac, I., Durré, T., Maertens, L., Detry, B., Blacher, S., Gilles, C., Péqueux, C., et al. (2015) · Neoplasia · doi:10.1016/j.neo.2015.07.002 · Cited by 16
Scherzed, A., Hackenberg, S., Froelich, K., Rak, K., Schendzielorz, P., Gehrke, T. E., Hagen, R., & Kleinsasser, N. H. (2015) · Oncology Reports · doi:10.3892/or.2015.4383 · Cited by 17
Mesenchymal stem cell homing towards cancer cells is increased by enzyme activity of cathepsin D
Vangala, G., Imhoff, F. M., Squires, C. M. L., Cridge, A. G., & Baird, S. K. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.07.007 · Cited by 19
Liver Disease and Cell Therapy: Advances Made and Remaining Challenges
Khan, S., Mahgoub, S., Fallatah, N. A., Lalor, P. F., & Newsome, P. N. (2023) · Stem Cells · doi:10.1093/stmcls/sxad029 · Cited by 17
Mesenchymal stem cell-derived exosomes for management of prostate cancer: An updated view
Arab, F. L., Hoseinzadeh, A., Hafezi, F., Mohammadi, F. S., Zeynali, F., Tehran, M. H., & Rostami, A. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112171 · Cited by 19
Mok, P. L., Cheong, S., Leong, C. F., Chua, K. H., & Ainoon, O. (2011) · Cytotechnology · doi:10.1007/s10616-011-9413-2 · Cited by 16
Chung, T., Hsieh, C.-C., Hsiao, J., Hsu, S.-C., Yao, M., & Huang, D. (2016) · RSC Advances · doi:10.1039/c6ra03453e · Cited by 15
Kim, R., Park, S., Lee, C. Y., Lee, J.-H., Kim, P., Oh, S., Lee, H., Lee, M. Y., Kim, J., Chung, Y., et al. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2909-5 · Cited by 15
Lupu-Haber, Y., Bronshtein, T., Shalom‐Luxenburg, H., D’Atri, D., Oieni, J., Kaneti, L., Shagan, A., Hamias, S., Amram, L., Kaneti, G., et al. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801589 · Cited by 15
Wang, P., Zhang, J., Zhang, Q., & Liu, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114035 · Cited by 17
Self-citationBone marrow contributions to fibrosis
MacKinnon, A. C., & Forbes, S. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.022 · Cited by 15
The Use of Normal Stem Cells and Cancer Stem Cells for Potential Anti-Cancer Therapeutic Strategy
Han, S.-W., Kim, Y. Y., Kang, W. K., Kim, H.-C., Ku, S., Kang, B.-C., & Yun, J.-W. (2018) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-018-0128-8 · Cited by 15
Mesenchymal stem cells targeting PI3K/AKT pathway in leukemic model
Ahmed, E. S. A., Ahmed, N. H., Medhat, A. M., Said, U. Z., Rashed, L. A., & Rahman, A. (2019) · Tumor Biology · doi:10.1177/1010428319846803 · Cited by 14
Kim, S.-H., Bang, S. H., Kang, S. Y., Park, K. D., Eom, J. H., Oh, I. U., Yoo, S. H., Kim, C., & Baek, S. Y. (2014) · Tissue and Cell · doi:10.1016/j.tice.2014.10.003 · Cited by 19
Mesenchymal Stem/Stromal Cells in Cancer: from Initiation to Metastasis
Zheng, Z., Li, P., Shen, F., Shi, Y., & Shao, C. (2022) · Archives of Medical Research · doi:10.1016/j.arcmed.2022.11.001 · Cited by 14
Mesenchymal stem cells‐ an excellent therapeutic agent for cancer
TomyTomcy, A., & Sindhu, E. R. (2023) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13969 · Cited by 17
Stem Cell-Based Therapies for Cancer
Bhere, D., & Shah, K. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.012 · Cited by 14
Kerrigan, B. C. P., Hossain, A., Yamashita, S., & Lang, F. F. (2018) · Progress in neurological surgery · doi:10.1159/000469686 · Cited by 14
Rajendran, R. L., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i12.1492 · Cited by 14
ALKHURIJI, A. F., Alsaiari, S. G., Alomar, S. Y., Alnafjan, A. A., Alobaid, H. M., & El‐Khadragy, M. F. (2021) · Bioscience Reports · doi:10.1042/bsr20204356 · Cited by 14
Walter, S. G., Scheidt, S., Nißler, R., Gaisendrees, C., Zarghooni, K., & Schildberg, F. A. (2021) · Cancers · doi:10.3390/cancers13061466 · Cited by 16
Moradi-Gharibvand, N., Setayeshmehr, M., Kazemi, M., Safaee, A., Khorsandi, L. S., Nejad, D. B., Hasheminia, S. J., & Hashemibeni, B. (2022) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.350238 · Cited by 17
Lee, H. J., Yang, H.-M., Choi, Y., Park, S., Moon, S., Lee, Y., Sung, Y. C., & Kim, S. J. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e3182710401 · Cited by 14
Jabbarpour, Z., Kiani, J., Keshtkar, S., Saidijam, M., Ghahremani, M. H., & Ahmadbeigi, N. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29371 · Cited by 15
Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence
Kiaie, N., Ghanavati, S. P. M., Miremadi, S. S., Hadipour, A., & Aghdam, R. M. (2021) · International Journal of Stem Cells · doi:10.15283/ijsc20182 · Cited by 14
Hurst, D. R., & Welch, D. R. (2007) · Nature Medicine · doi:10.1038/nm1107-1289 · Cited by 14
Higgs, J. T., Lee, J. H., Wang, H., Ramani, V. C., Chanda, D., Hardy, C., Sanderson, R. D., & Ponnazhagan, S. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017007310 · Cited by 13
Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives
Elkhenany, H. A., Shekshek, A., Abdel‐Daim, M. M., & El‐Badri, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_441 · Cited by 15
The effects of mesenchymal stem cells on the chemotherapy of colorectal cancer
Wang, M., Li, J., Wang, D., Xin, Y., & Liu, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114373 · Cited by 15
Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors?
ElShamy, W. M., Sinha, A., & Said, N. A. (2016) · Stem Cells International · doi:10.1155/2016/4829106 · Cited by 14
Mesenchymal Stromal Cells for Antineoplastic Drug Loading and Delivery
Petrella, F., Rimoldi, I., Rizzo, S., & Spaggiari, L. (2017) · Medicines · doi:10.3390/medicines4040087 · Cited by 14
Lee, M. W., Park, Y. J., Kim, D. S., Park, H. J., Jung, H. L., Lee, J. W., Sung, K. W., Koo, H. H., & Yoo, K. H. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9806-0 · Cited by 14
Tunoğlu, E. N. Y., Genç, D., Farooqı, A. A., Tunoğlu, S., Zeybek, Ü., Akkoç, T., & Yaylım, İ. (2020) · Anticancer Research · doi:10.21873/anticanres.14577 · Cited by 13
Ghollasi, M., Ghasembaglou, S., Rahban, D., Korani, M., Motallebnezhad, M., Asadi, M., Zarredar, H., & Salimi, A. (2021) · International Journal of Stem Cells · doi:10.15283/ijsc20146 · Cited by 13
Metadata
- Authors
- Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., Zhang, J., Raffeld, M., Rogers, T. B., Stetler-Stevenson, W., Frank, J. A., Reitz, M., & Finkel, T.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Maryland Biotechnology Institute (US)
- National Institutes of Health (US)
- Flow Cytometry Core Facility (CH)
- 1Laboratory of Molecular Biology, Cardiovascular Branch,
- National Heart, Lung, and Blood Institute (US)
- University of Maryland, Baltimore (US)
- National Cancer Institute (UA)
- 4National Cancer Institute; and
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-04-24
- Volume
- 203
- Issue
- 5
- Pages
- 1235-1247
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2121206
- OpenAlex
- W2163234891
- Cited by
- 747
- References
- 60
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 20 · 2023: 31 · 2022: 25 · 2021: 34 · 2020: 37 · 2019: 41 · 2018: 38 · 2017: 28 · 2016: 53 · 2015: 56 · 2014: 38 · 2013: 79 · 2012: 51
- FWCI
- 14.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Cancer Institute (1R01 CA09905-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- mesenchymal stem cells, Kaposi's sarcoma, anticancer activity, Akt signaling, E-cadherin, cell-cell contact, tumor stroma, stem cell homing, tumor suppression, stem cell therapy
- MeSH terms
- Animals, Disease Models, Animal, Enzyme Activation, Male, Mice, Nude, Neoplasm Transplantation, Neoplasms, Experimental, Sarcoma, Kaposi, Transplantation, Heterologous, Tumor Cells, Cultured, Stromal Cells, Graft vs Tumor Effect, Mesenchymal Stem Cell Transplantation, Oncogene Protein v-akt, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.